20 articles
Clinical trial tests whether senolytic compounds can reduce cellular aging burden and improve bone health markers in older adults.
Clinical trial tests whether dasatinib plus quercetin can reduce liver scarring in fatty liver disease patients.
Small trial tests whether dasatinib plus quercetin can improve brain blood flow and cognition in at-risk older adults.
A completed Phase 1/2 pilot trial tested whether the senolytic duo D+Q penetrates the brain in early Alzheimer's disease.
A Phase 2 pilot trial investigates whether the natural senolytic compound fisetin can reduce dysfunction and complications in COVID-19 patients.
A sponsored 90-day trial of enhanced-absorption quercetin targeting cholesterol, blood sugar, and metabolic age was terminated before completion.
Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.
120-person trial tested whether Oligonol could reduce muscle loss and cardiovascular risks in middle-aged and older adults.
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
First major clinical trial tests whether resveratrol, found in red wine, can slow Alzheimer's progression through sirtuin activation.
Small pilot study tests whether acarbose, a diabetes medication, can slow aging processes in healthy older adults through microbiome changes.
58-person trial compared resveratrol's effects to calorie restriction on insulin sensitivity, gene expression, and cardiovascular markers.
A Phase 2 trial explores whether cilostazol, a blood thinner with brain-protective effects, can slow memory loss in MCI patients.
University of Florida researchers tested whether resveratrol supplements could improve mitochondrial function and physical performance in seniors.
Natural Monarda didyma supplement tested in 81-person study for anti-aging effects. Results could reshape longevity strategies.
Singapore trial tests ancient herbal remedy against placebo for hormone-related dry eye in 150 postmenopausal women.
A completed trial investigates whether replenishing glutathione precursors can reverse metabolic dysfunction in elderly adults.
A completed trial tests whether daily Nordic berry beverages can sharpen cognition in healthy adults over 12 weeks.
A Phase 1/2 trial tests whether dexmedetomidine can enhance the brain's glymphatic system to clear amyloid and tau during sleep.
A Phase 3 trial examines whether bococizumab slashes LDL in statin-treated patients at elevated cardiovascular risk.
